VRSN
62
-2
EW
41
5
URI
49
-7
QRVO
9
-2
PPG
64
-4
COP
40
-4
HUM
41
-2
EQIX
60
-2
AIZ
64
-4
HOG
35
-3
DG
27
4
MAC
67
-7
HSY
45
-6
GOOG
81
10
GWW
58
-2
URBN
72
2
KEY
31
-2
L
55
-3
FTI
69
-2
ALLE
37
-4
VRSN
62
-2
EW
41
5
URI
49
-7
QRVO
9
-2
PPG
64
-4
COP
40
-4
HUM
41
-2
EQIX
60
-2
AIZ
64
-4
HOG
35
-3
DG
27
4
MAC
67
-7
HSY
45
-6
GOOG
81
10
GWW
58
-2
URBN
72
2
KEY
31
-2
L
55
-3
FTI
69
-2
ALLE
37
-4
Financhill
Back

Innovent Biologics 10K Form

Buy
69

IVBXF
Innovent Biologics

Last Price:
4.86
Seasonality Move:
4.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IVBXF News And Ratings

See the #1 stock for the next 7 days that we like better than IVBXF

IVBXF Financial Statistics

Sales & Book Value

Annual Sales: $877.36M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $1.05
Price / Book: 4.62

Profitability

EPS (TTM): -0.11260
Net Income (TTM): $-178.06M
Gross Margin: $716.72M
Return on Equity: -10.76%
Return on Assets: -6.54%

Innovent Biologics Earnings Forecast

Key Innovent Biologics Financial Ratios

  • The Gross Profit Margin over the past 6 years for IVBXF is 81.69%.
  • The Selling, General & Administrative Expenses for IVBXF have been equal to 62.05% of Gross Profit Margin.
  • The Research & Development expenses have been 35.89% of Revenue.
  • The Interest Expense is -9.59% of Operating Income.
  • The Net Earning history of IVBXF is -16.56% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

Innovent Biologics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: IVBXF
Website: innoventbio.com

Debt

Debt-to-Equity Ratio: 0.26
Current Ratio: 2.68
Quick Ratio: 2.46

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IVBXF Technical Analysis vs Fundamental Analysis

Buy
69
Innovent Biologics (IVBXF) is a Buy

Is Innovent Biologics a Buy or a Sell?